Phospholipases catalyse the cleavage of cellular phospholipids leading to the liberation of lipid second messengers of signal transduction. In most cell types, phospholipase A2 is responsible for the liberation of arachidonic acid after cellular stimulation and thus initiates the production of biologically active eicosanoid metabolites. T h e majority of the phospholipase A2 activity in most cells is catalysed by a calcium-independent phospholipase A2 (iPLAz) which demonstrates selectivity for substrates containing a vinyl ether linkage at the sn-1 position (plasmalogens) and arachidonic acid at the sn-2 position. We first identified iPLA2 activity in myocardium in 1985
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[ 11 and subsequent studies have demonstrated that iPLAz is also the major phospholipase A2 in brain, smooth muscle, and pancreatic /? cells [2-51. In contrast, cPLA2 is the major phospholipase A2 in many circulating cells (e.g. platelets) [6]. Because of the apparent unique nature of myocardial phospholipase Az activity (i.e. calcium independence) we undertook purification of this enzyme; this was facilitated by the demonstration that it possessed an ATP binding site [7] . Remarkably, ATP both activated and stabilized myocardial iPLA2 enzymic activity [8] . We purified a 40kDa polypeptide by ATP affinity chromatography and demonstrated that the 40 kDa polypeptide was radiolabelled after treatment with the mechanism-based inhibitor (BEL) [9, lo] . However, we were not able to obtain sequence data for the purified myocardial enzyme due to its low abundance. Subsequently, Jones and co-workers identified the sequence of an 80 kDa iPLA2 in Chinese hamster ovary cells [ 111 which possessed an identical active site to that of a previously purified iPLA2 from potatoes (i.e. The active fraction from the Mono-Q-chromatography (MQ) was incubated with W-7 agarose beads in the presence of I mM CaCI2. The mixture was centrifuged, the supernatant was reserved (Sw), and the pellet was washed and resuspended in 4 mM EGTA (Pw Although the iPLA2 neither required Ca2+ as an obligatory cofactor in catalysis, nor used Ca2+ during its membrane association, these factors alone did not formally exclude a role for Ca2+ in the regulation of this enzyme. Moreover, since alterations in Ca2+ homoeostasis play important roles in cellular activation, and mobilization of Ca2+ has been intimately associated with the release of arachidonic acid from many cell types, we sought to identify a pathway that could integrate alterations in Ca2+ homoeostasis and intracellular arachidonic acid mobilization with iPLA2. In initial experiments, we demonstrated that Ca2+ inhibited over 80% of crude myocardial cytosolic phospholipase activity but did not inhibit purified iPLAz [ 141. Furthermore, the inhibition of purified myocardial iPLAz could be reconstituted with a cytosolic cofactor which was trypsin sensitive. Collectively these experiments demonstrated that a protein constituent present in myocardial cytosol was responsible for the calcium-mediated inhibition of myocardial phospholipase Az activity. Subsequently, the protein constituent mediating these effects was purified by Mono Q anion-exchange chromatography revealing an 18 kDa doublet which collapsed to a single band in the presence of EGTA [14]. Since this electrophoretic behaviour was highly suggestive for calmodulin, we performed Western blot analysis with a monoclonal antibody directed against calmodulin; this recognized the 18 kDa protein doublet [ 141. Multiple other lines of experimental evidence documented the identity of the protein mediating calcium-dependent inhibition of iPLA2 as calmodulin including: (i) calcium-dependent precipitation of the factor with W-7 agarose beads ( Figures 1A-1C) ; (ii) reconstitution of calcium-mediated iPLA2 inhibition with authentic calmodulin ( Figure 1D) One interpretation of the potential biological significance of the association of calmodulin with iPLA2 in signal transduction cascades was that the release of arachidonic acid in activated cells was dependent upon the depletion of Ca2+ from specific subcellular loci; this resulted in the release of calcium-dependent calmodulinmediated inhibition of iPLA2. Previous studies have demonstrated that A-10 smooth muscle cells contain an arginine vasopressin (AVP) receptor, the occupancy of which results in the activation of phospholipase C and the subsequent generation of inositol 1,4,S-trisphosphate (IP,) leading to the release of calcium ion from internal calcium stores. In previous work, we utilized BEL to demonstrate that the AVPinduced release of arachidonic acid in A-10 cells was largely due to iPLA, [15] . Accordingly, we examined the possibility that depletion of intracellular calcium stores activates iPLA, by a three-pronged approach. First, we investigated the importance of inhibition of phospholipase C on arachidonic acid release mediated by One conclusion consistent with these results is that phospholipase C-mediated depletion of internal calcium stores results in the activation of iPLA,. T o determine whether intracellular calcium store depletion in the absence of both receptor occupancy and IP3 production is a sufficient stimulus for iPLA, activation, with respect to the second approach, we examined [3H]arachidonic acid release in the presence of three structurally disparate inhibitors of sarcol endoplasmic reticular calcium ATPases; treatment of prelabelled A-10 cells with the inhibitor thapsigargin resulted in the robust release of [3H]arachidonic acid which could be completely inhibited by BEL ( Figure Za) . Furthermore, the magnitude of thapsigargin-mediated arachidonic acid release was not altered when cells were stimulated in media containing either calcium, EGTA, or EGTA and BAPTA-AM (Figure 2a) . Examination of the fura ' 2 fluorescence tracings demonstrated that BAPTA-AM was effective at preventing increases in intracellular calcium after thapsigargin treatment (Figure 2b ). Since arachi- Collectively, these results identify a novel paradigm which links alterations in calcium ion homoeostasis to the calmodulin-mediated regulation of iPLA, through the depletion of internal calcium stores. These studies thus provide a novel mechanism which couples the activation of phospholipase C to phospholipase A,, thereby integrating receptor-mediated increases in phosphatidylinositol hydrolysis with arachidonic acid release mediated by iPLA2.
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